Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
New words:
aggregate, Agreement, Anhui, appointed, Appointment, Beijing, Biotech, BNC, board, CEO, Chairman, Chi, Closing, collectively, Concurrent, connection, Dadi, Departure, Duoweite, Fengexin, Floor, Futian, Group, health, herbal, Hotel, HuakeHongzhang, iii, Jiang, Jiangsu, Jingquan, July, Jun, Lu, mailing, October, owed, Pharmaceutical, President, Presidentand, price, refer, reference, resignation, resigned, responsible, Schedule, serve, served, set, Shenzhen, Sheraton, skincare, Tower, Treasurer, Vice, Wu, Xiong
Removed:
aware, equal, performed, recognition, require, Topic
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 31.1 Certification of the Company?s Principal Executive Officer, Pursuant to Section 302 of the Sarbanes-oxley Act of 2002, with Respect to the Registrant?s Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2012.
- 31.2 Certification of the Company?s Principal Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002, with Respect to the Registrant?s Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2012.
- 32.1 Certification of the Company?s Principal Executive Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- 32.2 Certification of the Company?s Principal Financial Officer, Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
5V similar filings
Filing view
External links